| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V118909 | FYN Y531F Recombinant Human Active Protein Kinase | FYN Y531F recombinant human active protein kinase is an oncogene that directly activates YANK2 by phosphorylation of the Y110 site. | |
|
V116671 | Hck-IN-3 | Hck-IN-3 (compound 2D) is an orally effective HCK inhibitor (KD = 3.92 μM). | |
|
V137354 | Hibarimicin A | 208588-76-5 | Hibarimicin A is a tyrosine kinase inhibitor found in the subspecies *Hibaria* of *Microsporum roseum*. |
|
V137356 | Hibarimicin C | 208588-83-4 | Hibarimicin C is a tyrosine kinase inhibitor. |
|
V137357 | Hibarimicin D | 208588-87-8 | Hibarimicin D is a tyrosine kinase inhibitor. |
|
V109967 | LCK degrader-3 | 3095032-59-7 | LCK Degrader-3 (Compound 20) is a CRBN-based LCK molecular glue degrader. |
|
V140419 | MRT-10350 | MRT-10350 is a cereblon-based HCK molecular adhesive degrader. | |
|
V0667 | PP2 (AG1879) | 172889-27-9 | PP2 (also known as AG 1879; AG-1879) a novel, potent,reversible, and ATP-competitiveand selective Src family kinase inhibitor with potential anticancer activity. |
|
V94145 | Saracatinib-d3 | 2200301-36-4 | Saracatinib-d3 (AZD0530-d3) (ZG5129) is a deuterated derivative of Saracatinib. |
|
V98063 | SKLB646 | 1970149-05-3 | SKLB646 is an oral multi-targeted kinase inhibitor. |
|
V3287 | UM-164 | 903564-48-7 | UM-164, a dasatinib analogue, isa potent and dual inhibitor of the Src/p38 kinase with potential anticancer activity for Triple-Negative Breast Cancer (TNBC). |